OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Bone and Mineral Research is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Prevalence and trends in low femur bone density among older US adults: NHANES 2005–2006 compared with NHANES III	196
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop	147
Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study	121
Machine Learning Solutions for Osteoporosis—A Review	98
Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post‐Fracture Treatment, and All‐Cause Mortality	98
Postpubertal Architectural Developmental Patterns Differ Between the L3 Vertebra and Proximal Tibia in Three Inbred Strains of Mice	97
Burosumab for the Treatment of Tumor-Induced Osteomalacia	93
Skeletal Biology and Disease Modeling in Zebrafish	87
Piezo1 Inactivation in Chondrocytes Impairs Trabecular Bone Formation	73
Racial and Ethnic Disparities in Bone Health and Outcomes in the United States	70
The diverse origin of bone-forming osteoblasts	69
Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism	69
Fractures After Denosumab Discontinuation: A Retrospective Study of 797 Cases	62
Bone Elasticity and Ultrasound Velocity Are Affected by Subtle Changes in the Organic Matrix	62
Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis: A 2-Year Randomized Study	56
Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis	55
Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis	46
Glutamine Metabolism in Osteoprogenitors Is Required for Bone Mass Accrual and PTH-Induced Bone Anabolism in Male Mice	45
Fgf9 Negatively Regulates Bone Mass by Inhibiting Osteogenesis and Promoting Osteoclastogenesis Via MAPK and PI3K/AKT Signaling	44
Metabolomics Insights into Osteoporosis Through Association With Bone Mineral Density	43
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With	42
Ectopic Calcification and Hypophosphatemic Rickets: Natural History of ENPP1 and ABCC6 Deficiencies	42
Vitamin D and Muscle Health: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials	41
Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses	40
Melatonin Prevents Cartilage Degradation in Early-Stage Osteoarthritis Through Activation of miR-146a/NRF2/HO-1 Axis	39

Runt-related transcription factor-2 (Runx2) is required for bone matrix protein gene expression in committed osteoblasts in mice	39
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease	38
Opportunistic Osteoporosis Screening Using Chest Radiographs With Deep Learning: Development and External Validation With a Cohort Dataset	38
Sarcopenia Definitions as Predictors of Fracture Risk Independent of FRAX®, Falls, and BMD in the Osteoporotic Fractures in Men (MrOS) Study: A Meta-Analysis	37
Management of Primary Hyperparathyroidism	35
The Mineralization Regulator ANKH Mediates Cellular Efflux of ATP, Not Pyrophosphate	34
Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk	34
Macrophages and Bone Remodeling	33